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Abstract.  Neuronal responses to extracellular matrix 
(ECM) constituents are likely to play an important 
role in nervous system development and regeneration. 
We have studied the interactions of a neuron-like rat 
pheochromocytoma cell line,  PC12, with ECM pro- 
tein-coated substrates.  Using a quantitative cell attach- 
ment assay, PC12 cells were shown to adhere readily 
to laminin  (LN) or collagen IV (Col IV) but poorly to 
fibronectin (FN). The specificity of attachment to 
these ECM proteins was demonstrated using ligand- 
specific antibodies and synthetic peptides.  To identify 
PC12 cell surface proteins that mediate interactions 
with LN, Col IV, and FN, two different antisera to 
putative ECM receptors purified from mammalian 
cells were tested for their effects on PC12 cell adhe- 
sion and neuritic process outgrowth.  Antibodies to a 
140-kD FN receptor heterodimer purified from Chi- 
nese hamster ovarian cells (anti-FNR; Brown, P. J., 
and R. L. Juliano,  1986, J.  Cell Biol.,  103:1595-1603) 
inhibited attachment to LN and FN but not to Col IV. 
Antibodies to an ECM receptor preparation purified 
from baby hamster kidney fibroblastic cells (anti- 
ECMR; Knudsen,  K. A.,  P. E.  Rao, C.  H. Damsky, 
and C.  A.  Buck,  1981, Proc. Natl. Acad.  Sci.  USA., 
78:6071-6075)  inhibited attachment to LN, FN, and 
Col IV,  but did not prevent attachment to other adhe- 
sive substrates. In addition to its effects on adhesion, 
the anti-ECMR serum inhibited both PC12 cell and 
sympathetic neuronal process outgrowth on LN sub- 
strates.  Immunoprecipitation of surface-iodinated or 
[3H]glucosamine-labeled PC12 cells with either the 
anti-FNR or anti-ECMR serum identified three prom- 
inent cell surface glycoproteins of 120, 140, and  180 
kD under nonreducing conditions. The L20-kD glyco- 
protein,  which could be labeled with 32P-orthophos- 
phate and appeared to be noncovalently associated 
with the 140- and  180-kD proteins,  cross reacted with 
antibodies to the 13-subunit (band 3) of the avian inte- 
grin complex, itself a  receptor or receptors for the 
ECM constituents LN, FN, and some collagens. 
N 
'ERVOOS system development is characterized by com- 
plex and reproducible patterns  of neuronal  migra- 
tion, axon extension, target recognition, and synapse 
formation,  processes that depend on the ability of neurons 
to extract and respond to information  present in the cellular 
and aceUular environments  in which they develop.  Several 
recent observations suggest that protein constituents  of the 
extracellular matrix (ECM)  l influence some aspects of neu- 
ronal differentiation. First, purified constituents of the ECM, 
most notably the basement membrane glycoprotein  laminin 
(LN), are known to promote neuronal process outgrowth and 
survival in vitro (Manthorpe et al., 1983; Rogers et al., 1983; 
1. Abbreviations used in this paper: Col IV, collagen IV; CSAT antibody, 
cell substmte attachment antibody; ECM, extracellular matrix, ECMR, ex- 
tmcellular matrix receptor; FNR,  fibronectin receptor; FN,  fibronectin; 
LN, laminin; NGF,  nerve growth factor;  NRK, normal rat kidney;  SCG, 
superior cervical ganglion. 
Edgar et al.,  1984; Lander et al.,  1983, 1985a, b; Davis et 
al.,  1985; Calof and  Reichardt,  1984, 1985). Fibronectin 
(FN) and, to a lesser extent, collagen type I and collagen type 
IV (Col IV) also influence process outgrowth from a variety 
of avian and mammalian  neurons (Akers et al., 1981; Rogers 
et al.,  1983, 1985; Carbonetto et al.,  1983; Bozyczko and 
Horwitz, 1986; Tomaselli et al.,  1986a; Hall et al.,  1987). 
Second, neuronal process outgrowth on the surfaces of some 
nonneuronal  cells in vitro depends on the function  of neu- 
ronal receptors for ECM proteins as well as cell-cell adhe- 
sion molecules (Tomaselli et al., 1986a; Bixby et al., 1987). 
Finally, for neurons in peripheral autonomic ganglia, moto- 
neurons in the spinal cord, and ganglion cells of the retina, 
axon initiation occurs in regions that are likely to contain LN 
and/or FN (Rogers et al., 1986; Bronner-Fraser,  1986; Adler 
et al.,  1985; Easter et al.,  1984; Halfter and Deiss,  1984, 
1986), suggesting a role for these ECM molecules in axon 
growth in vivo. 
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tiation are mediated by receptors for these molecules on the 
neuronal membrane. For example, for avian sensory, para- 
sympathetic, and retinal neurons, attachment and process 
outgrowth on LN, FN, and Col IV depend on a set of neu- 
ronal cell surface glycoproteins recognized by two monoclo- 
nal antibodies, cell substrate attachment antibody (CSAT) 
and JG22 (Bozyczko and Horwitz,  1986; Tomaselli et al., 
1986a; Hall et al., 1987). A group of integral membrane gly- 
coproteins of 110-165 kD purified by these antibodies appears 
to function as a receptor or receptors for FN, LN, and at least 
some collagens (Horwitz et al., 1985; Akiyama et al., 1986; 
Buck et al., 1986; Hall et al., 1987). The recent cloning and 
sequencing of the ll0-kD (band 3) component (Tamkun et 
al., 1986), has established that glycoproteins recognized by 
the CSAT and JG22 antibodies belong to the integrin family 
of adhesive protein receptor heterodimers present on a wide 
variety of avian and mammalian cells (Pytela et al.,  1986; 
Kishimoto et al.,  1987; Hemler et al.,  1987; reviewed in 
Hynes, 1987). 
The present study was motivated by a search for a neuron- 
like cell line whose behavior mimics that of neuronal cells 
to purified ECM molecules. Such a cell line would be useful 
for biochemical and cell biological studies of neuron/ECM 
interactions since pure neuronal cultures are difficult to ob- 
tain in large quantities. The rat pheochromocytoma cell line, 
PC12, displays properties of differentiated sympathetic neu- 
rons after long-term exposure to nerve growth factor (NGF), 
including process outgrowth, electrical excitability, and func- 
tional synapse formation (Tischler and Greene, 1975; Schu- 
bert et al., 1977). In the present study, we used two antisera 
that recognize mammalian homologs of avian ECM recep- 
tors identified by the CSAT antibody to identify PC12 cell 
surface glycoproteins involved in interactions with the ECM 
proteins LN, Cot IV, and FN: one serum was raised to a het- 
erodimeric FN receptor immunopurified from Chinese ham- 
ster ovary (CHO) cells (henceforth referred to as anti-FNR; 
Brown and Juliano, 1986) and the other was raised to a 120- 
160-kD ECM receptor preparation purified from baby ham- 
ster  kidney (BHK)  cells  (henceforth referred to  as  anti- 
ECMR; Knudsen et al.,  1981; Damsky et al.,  1982).  We 
present evidence for both a structural and functional rela- 
tionship between the PC12 cell surface glycoproteins recog- 
nized by these antisera and ECM receptors belonging to the 
integrin family  of  adhesive protein receptors identified  by the 
CSAT antibody on avian cells. Some of these results have 
been reported in abstract form (Tomaselli  et al.,  1986b). 
Materials and Methods 
Animals 
Newborn Sprague-Dawley rat pups were purchased from Bantin and King- 
man (Fremont, CA). 
Chemicals and Reagents 
Laminin and  collagen IV  were purified from Engelbreth-Holm-Swarm 
(EHS) sarcoma tumors using published methods (Kleinman et al.,  1982; 
Timpl et al., 1982) and were the generous gifts of Drs. A. D. Lander, L  L. 
Bixby, J. Winter, and D.  Hail. Human plasma fibronectin was from Col- 
lahorative Research, Inc. (Lexington, MA). Rat tail collagen was prepared 
as described in Bornstein (1958).  Aquasol was purchased from New En- 
gland Nuclear (Boston, MA). N-octyl-13-~glucopyranoside was purchased 
from Calbiochem (La Jolla, CA). Protein A coupled to Sepharose CL-4B 
and Sepharose CL-4B were purchased from Pharrnacia (Piscataway,  NJ). 
Affi-gel 10  was purchased from BioRad Laboratories (Richmond, CA). 
ffNerve growth factor ([I-NGF) was purified from adult male mouse sub- 
maxillary glands as described (Mobley et al., 1976) and was a generous gift 
from Dr.  David Shelton. The Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) and 
Gly-Arg-Gly-Glu-Ser-Pro (GRGESP)  hexapeptides were purchased from 
Peninsula Laboratories, Inc. (Belmont, CA). All other chemicals were from 
Sigma Chemical Co. (St. Louis, MO). 
Antibodies 
Rabbit anti-LN serum was prepared by Dr. Janet Winter using LN purified 
from the EHS sarcoma. A rabbit antiserum to the purified E3 fragment of 
LN (Ott et al.,  1982) was the generous gift of Dr. D. Hall. Rabbit anti- 
N-CAM serum was the generous gift of Dr. J. L. Bixby. Rabbit anti-NILE 
glycoprotein (or anti-Ng-CAM) was kindly provided by Dr. W. Stallcop. 
Affinity-purified  antibodies to murine collagen IV were purchased from Dr. 
H.  Furthmayr  (Yale  University,  New  Haven,  CT).  An antiserum  to  a 
purified preparation of 140-kD adhesion-related, integral membrane glyco- 
proteins purified from BHK cells was generated in goats as previously de- 
scribed by Dr.  K. Knudsen (anti-gpl40, here referred to as anti-ECMR; 
Knudsen et al.,  1981; Damsky et al.,  1982). F,b fragments of anti-ECMR 
IgG were prepared as described in Parham (1986). IgG from a goat antise- 
rum to a purified 140-kD FN receptor heterodimer from CHO cells was the 
very generous gift of Dr. R. Juliano (here referred to as anti-FNR; Brown 
and Juliano,  1985, 1986).  A  rabbit serum against the purified 13rsubunit 
(band 3) of the avian CSAT/integrin ECM receptor complex was a very 
generous gift from Dr. C. Buck (Buck et al.,  1986). 
Cell Cultuw 
Rat pheochromocytoma (PC12)  cells (Tischler and Greene,  1975) were 
grown in monolayer culture in DME with 4.5 g/1 glucose (DME H-21; 
UCSF Cell Culture Facility) supplemented with 10% heat-inactivated horse 
serum, 5% newborn calf serum, glutamine (2 mM), and penicillin/strep- 
tomycin (100 U/ml) and were carded for no more than I0 passages. PC12 
cells were "primed" with NGF as described (Greene, 1977; Greene et al., 
1982). For studies on process outgrowth, NGF-primed PCI2 cells were pas- 
saged and mechanically divested of their neurites by trituration through a 
narrow bore 9-inch pasteur pipet.  After washing three times in growth 
medium, cells were resnspended at  a  concentration of  105  cells/ml in 
growth medium with or without 50  ng/ml NGF (see Table and Figure 
legends), and 100 ttl of this cell suspension were added per welt (0.28 cm  2 
surface area). 
A  mouse muscle cell line, C2 (Yaffe and Saxel,  1977), was grown in 
monolayer culture in DME with I g/l glucose (DME H-16; UCSF Cell Cul- 
ture Facility) supplemented with 20%  FCS, 0.5%  chick embryo extract 
(Gibco, Grand Island, NY), glutamine (2 mM), and penicillin-streptomycin 
(lO0  U/n). 
Sympathetic neurons were enzymatically dissociated from newborn rat 
superior cervical ganglia (SCG) as previously described (Lander et al., 
1982) and were grown in DME H-21 supplemented with 10% heat-inacti- 
vated horse serum, glutamine  (2 mM), and penieillin/saelXonr~in  (100  U/ml). 
The normal rat kidney (NRK) and BHK fibroblastic cell lines were grown 
in monolayer culture in DME H-21 supplemented with 10% FCS, glutamine 
(2 mM), and penicillin/streptomycin (100 U/ml). 
Substrate Preparation 
LN, FN, and Col IV were diluted in Ca++/Mg++-free PBS to the concen- 
trations indicated in figure legends. Poly-D-lysine (PDL) was dissolved in 
H20 at a concentration of 1 mg/ml. 100 Ixl of the appropriate solution were 
used to coat the 0.28-cm  2 surface area of a 96-well tissue culture well (cat. 
No. 76-032-05;  Linbro, Flow Laboratories, Hamden, CT) by incubation 
overnight at 4~  Plates to be used for PC12 cell process outgrowth assays 
were washed five times with sterile PBS before the addition of about 104 
ceUs/0.28 cm  2 well in 1{30 p.1 of growth medium. For sympathetic neurite 
outgrowth assays, neurons were plated in microwells that had first been 
coated with poly-D-lysine (1  mg/ml), washed with H:O, and then coated 
with LN or FN. 
Cell Attachment Assay 
The assay used to measure attachment of PC12 cells is similar to that used 
by Hall et al.  (1987) to measure retinal cell attachment. Briefly,  protein- 
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with 10 mg/ml BSA in PBS. 100 ~tl of PBS (with 1 mM CaCI2 and 0.5 mM 
MgCI2) or PBS plus 2 x  concentration of the desired antibodies or pep- 
tides were added to each well. Antisera used in attachment assays were heat 
inactivated at 56~  for 1 h before use. PC12 cells to be used in the attach- 
ment assays were  harvested  in  5  mM  EDTA  in  Ca++/Mg++-free  PBS, 
washed twice in PBS containing 1 mM Ca  ++ and 0.5 mM Mg  ++, and ad- 
justed to a density of 5  ￿  105 ceils/ml in Ca++/Mg++-containing  PBS. 100 
~tl of this cell suspension (5  ￿  104 calls) were added to each 96-well plate 
well. To ensure rapid and even distribution of the added cells onto the bot- 
tom of the wells, plates were spun at 100 g for 2 rain. Cells were allowed 
to attach for 90 rain at 37"C. Unattached cells were dislodged from the bot- 
tom of the well by forceful ejection of 50 Itl of PBS to each of two sides 
of the microwell and then supernatants and unattached cells were removed. 
This wash procedure was repeated once to ensure complete removal of unat- 
tached cells. Two different methods of quantitation were used in the present 
study. In one (of. Fig. 3), PC12 cells that had been labeled overnight with 
[35Slmethionine  were used. At the end of the assay, attached cells were ex- 
tracted in 100 I~1 of 1%  SDS in PBS, mixed with 5  ml of Aquasol, and 
counted in a scintillation counter. In the second method (cf. Table II; Figs. 
4 and 5), attached cells were fixed and stained with trypan blue as described 
(Koda et al.,  1986).  After rinsing with PBS, the A69o nm of individual 
wells was measured using a microtiter plate reader (Flow Laboratories, Inc., 
MeI.ean, VA). V~lls coated with 1 mg/ml poly-D-lysine served as the posi- 
tive control to which attachment to other substrates was compared. Using 
either method of  qnantitation, it was demonstrated that ,x,60-80% of  the in- 
put cells attached to poly-o-lysine-coated wells, compared with <2% on 
BSA-blocked plastic alone. All attachment experiments were repeated at 
least once with quantitatively similar results. 
Radiolabeling of  PC12, NRK, and BHK Cells 
PC12 cells were metabolically labeled for 16 h  with either 50 ~tCi/ml of 
[35S]methionine (Amersham Corp., Arlington Hts., IL) in methionine-free 
DME-H21  supplemented with  10%  normal growth medium or with 50 
~tCi/mi  of [3H-6-o]glucosamine (New England Nuclear, Boston, MA) in 
normal growth medium. PC12 cells were also labeled metabolically in sus- 
pension  with  100  I.tCi/ml  of 32P-orthopbosphate  (Amersham Corp.)  in 
phosphate-free DME H-21  plus 10%  normal growth medium and 50 IxM 
sodium vanadate for 3  h  at 37~  with gentle rocking.  Lactoperoxidase- 
catalyzed iodination of  PC12, NRK, and BHK cells was carded out as previ- 
ously described (Pesando et al.,  1981). 
lmmunoprecipitations 
For immunoprecipitations with the anti-ECMR serum, radiolabeled PCI2 
cells were washed three times in PBS and resuspended in PBS with 2 mg/ml 
hemoglobin at  a  concentration of ,,,5  ￿  l&  cells/ml.  20  ttl  of goat 
anti-ECMR serum or control goat serum were added to a  1-ml aliquot of 
a suspension of intact cells and the suspension was rocked for 2 h at 4~ 
(Giancotti et al., 1985). Cells were pelleted by centrifugation at 1,000 g for 
5 rain and the supernatants were removed. The cell pellets were extracted 
for 30 rain on ice in Ca++/Mg'~-containing PBS plus 100 mM n-octyl-fi-D- 
glucopyranoside (octylghicoside) and 1 mM phenylmethylsulfonylfluoride 
(PMSF), I mg/ml pepstatin A, and 1 mg/ml leupeptin. Detergent insoluble 
material was removed by centrif~gation at 12,000 g for 15 min at 4"C. The 
cleared cell lysates were diluted with an equal volume of PBS to bring the 
concentration of octylglucoside to 50 mM and were adsorbed twice (2 h 
each at 4~  with 100-~tl packed volume of Sepharose CL-4B that had been 
washed twice in PBS, plus 50 mM octylglucoside and 1 mM PMSF (wash 
buffer). Immune complexes were recovered from the supernatants by incu- 
bation for 30 min at 4~  with 50-1xl packed volume of protein A-Sepharose 
CL-4B that had been washed twice in wash buffer.  Protein A-Sepharose 
beads were recovered and washed five times with wash buffer by centrifuga- 
tion at 1,500 g for 1 rain. Proteins were eluted by heating at 100~  for 5 
rain in SDS gel sample buffer (Laemmli, 1970), with or without 5% 13-mer- 
eaptoethanol, and were frozen at -20~  until SDS gel analysis. Detergent 
extraction and immunoprecipitation of 32p-labeled PC12 cell proteins with 
the anti-ECMR serum was carded out as described above except that the 
extraction, immunopreeipitation, and washes were done in PBS plus 0.5% 
Triton X-100, 0.3%  sodium deoxycholate, 0.3%  SDS,  1 mM PMSF, and 
50 ~tM sodium vanadate. For immunoprecipitations with rabbit anti-CSAT 
band 3, rabbit anti-N-CAM, rabbit anti-Ng-CAM, or normal rabbit serum, 
labeled cells were extracted with 100 mM octylglucoside (anti-CSAT band 
3) or 1% Triton X-100 (anti-N-cAM and anti-Ng-CAM) before addition of 
20 I~l of the antisera. 
Immunoprecipitation of surface-iodinated PC12,  NRK, and BHK cells 
with anti-FNR IgG was performed as described (Brown and Juliano, 1986). 
Briefly,  labeled cells were extracted in 50 mM Tris HCI pH 7.5 with 150 
mM NaCI,  1% Triton X-100, and 2 mM PMSE Cell extracts were spun at 
12,000 g for 15 min at 4~  and the cleared cell lysates were adsorbed twice 
(2 h each at 4~  with BSA coupled to Atli-gel 10 (100-~tl packed volume 
of beads; 10 mg BSA/ml of gel). Anti-FNR IgG or control goat IgG were 
coupled to Afli-gel 10 at a concentration of 6 mg IgG/ml of gel following 
manufacturer's  instructions.  100  ttl  of  packed  beads  were  added  to 
precleared cell extracts and incubated for 4 h at 4~  Antibody-conjugated 
beads were recovered and washed five times with cell extraction buffer plus 
0.5% sodium deoxycholate and 0.1% SDS. Bound proteins were eluted as 
describexl  above and stored at  -20~  until use. 
SDS-PAGE and Antigen Blots 
Immunoprecipitates  were  analyzed  on  7%  polyacrylamide  SDS  gels 
(Laemmli,  1970) in the presence (reducing) or absence (non-reducing) of 
5 % 13-mercaptoethanol.  Coomassie Blue-stained and dried gels were ex- 
posed to Kodak XAR x-ray film at -80~  with intensifying screens (Dupont 
Lightning Plus, Wilmington, DE). The molecular mass standards used were 
myosin (200 kD), ~galactosidase (116 kD), phosphorylase a (97 kD), and 
BSA (68  kD). 
For  antigen  blots  using  antibodies  to  purified band  3  of the  avian 
CSAT/ECM receptor complex (anti-CSAT band 3),  •5  x  107  surface- 
labeled PC12 cells were incubated with 70 Ixl of the anti-ECMR serum and 
then extracted for immunoprecipitation as described above. Immune com- 
plexes recovered with protein A-Sepharose were run in a single lane of a 
7 % SDS gel under nonreducing conditions and electrophoretically trans- 
ferred to nitrocellulose paper by the method of Towbin (1979). The area of 
the nitrocellulose corresponding to the immunoprecipitated and transferred 
PC12 cell proteins was cut into two strips and incubated 3 h at 25~  with 
either the anti-CSAT band 3 serum or a control rabbit antiserum diluted 
1:100 in 50 mM Tris HCi pH ZS, 150 mM NaCI, and 5% nonfat dry milk 
(Carnation Co., Los Angeles, CA).  Unbound antibody was removed by 
washing five times (5 min each) in 50 mM "Iris HC1 pH 7.5, 150 mM NaCI, 
1% Triton X-100, 0.5% sodium deoxycholate, and 0.1% SDS. Bound anti- 
body was detected by incubating the nitrocellulose for 1 h at 25~  in goat 
anti-rabbit IgG coupled to horseradish peroxidase diluted 1:1,000 in 50 mM 
Tris HC1 pH 7.5, 150 mM NaCI, and 5% nonfat dry milk (Carnation Co.). 
Unbound second antibody was removed by washing as described above, and 
the antigen blot was developed using 1"1202 and 4-chloronapthol as de- 
scribed by Hawkes et al. (1982). The dried antigen blot was then subjected 
to antoradiography to visualize the PC12 cell proteins originally immuno- 
precipitated by the anti-EeMR serum. 
Microscopy 
Cultured cells were fixed in 2.5% glutaraldehyde in PBS plus 5% sucrose 
for 1 h at 25~  washed twice with PBS, and then viewed and photographed 
using a 40￿  water immersion lense (na =  0.70) on a Zeiss IM microscope 
using phase contrast optics. 
Results 
Characterization of  PC12 Cell Interactions with 
Purified ECM Proteins 
The ECM proteins LN and FN stimulate adhesion and pro- 
cess outgrowth by many types of neurons (Manthorpe et al., 
1983; Rogers et al., 1983, 1985; Hall et al., 1987). The ability 
of the neuronlike PC12 cell line to extend neurites on sub- 
strates coated with LN and FN was compared with the re- 
sponse of neonatal rat sympathetic neurons on these same 
substrates. To study neurite extension, PC12 cells were first 
differentiated by growth in 50 ng/ml NGF for 10 d.  These 
"NGF-primed" PC12  cells  (Greene,  1977) were then pas- 
saged onto substrates coated with either poly-D-lysine, LN, 
or FN and cultured for 24 h in the absence of added NGE 
Under these conditions, <10% of individual cells or small 
clumps of  cells regenerated neurites on poly-~lysine or FN, 
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Cells  Poly-o-lysine  LN  FN 
NGF-primed PC12 cells  7  +  1  44  5:2  9  +  3 
Rat sympathetic neurons  1  5:1  55  5:4  6  5:1 
Process outgrowth from NGF-primed PCI2 cells and neonatal rat sympathetic 
neurons on substrates coated with poly-o-lysine, LN, or FN in the absence of 
NGF.  NGF-primed PCI2  cells or dissociated rat sympathetic neurons were 
cultured 24 and 16 h, respectively, on substrates coated with poly-o-lysine (1 
mg/ml), LN (10 lag/ml),  or FN (20 lag/ml).  Fixed cells were scored for the 
percentage of individual cells (or small clumps of < 10 cells in the case of PC 12 
cells) with a process >2-ceU-diameter long. Values represent the average and 
range of determinations made on duplicate cultures run in parallel, At least 200 
cells or clumps of cells were counted for each value. 
Table II. PC12 Cell Attachment 
Attachment: percentage 
Substrate  of positive control 
Poly-o-lysine  100 
BSA  3  +  0.5 
Laminin  100  +  4 
Col  IV  106  +  21 
FN  19  5:2 
PCI2 cell attachment to substrates coated with poly-D-lysine  (1 mg/ml), BSA 
(I mg/ml), laminin (5 lag/ml), Col IV (2 I~g/ml), or FN (20 lag/nil). Each value 
represents the mean and standard deviation of determinations made on tripli- 
cate cultures run in parallel  and is expressed as the percentage of attachment 
relative to the positive control, poly-o-lysine. 
compared with 44%  on LN (Table I;  Fig.  1, A-C).  Dis- 
sociated sympathetic neurons showed a similar response to 
these substrates. In the absence of added NGF, <10% of the 
neurons extended processes in 16 h on either poly-o-lysine 
or FN,  while LN substrates supported process outgrowth 
from 55% of the neurons (Table I; Figure 1, D-F). In con- 
trast to previous studies using PC12 cells or sympathetic neu- 
rons (see Akeson and Warren,  1986;  Rogers et al.,  1983, 
1985), process outgrowth was studied here in the absence of 
added NGF, since NGF itself  has neurite outgrowth-promot- 
ing activity. Based on the apparent similarity between PC12 
cells and sympathetic neurons with respect to process out- 
growth on these adhesive substrates, experiments were done 
to characterize PC12  cell  interactions with LN and other 
ECM constituents in more detail. 
A  quantitative  assay  was  used  to  study  attachment  of 
undifferentiated PC12  cells to substrates coated with adhe- 
sive proteins. Using this assay, PC12 cells were shown to at- 
tach readily to poly-o-lysine, LN, or Col IV (Table II). By 
comparison, PC12 cells attached poorly to substrates coated 
with FN and failed to attach appreciably to substrates coated 
with BSA (Table II). Attachment of PC12 cells to LN or Col 
IV was accompanied by spreading and flattening of a large 
percentage of the cells within 2 h (Fig. 2, A and B). On FN 
or poly-D-lysine, PCI2 cells did not spread or flatten, but re- 
mained round and phase bright (Fig. 2,  C and D). 
PC12 cell attachment to LN and Col IV was concentration 
dependent (Fig. 3). Half-maximal attachment to LN or Col 
IV was attained at substrate-coating concentrations of •200 
and 60 ng/ml for LN and Col IV, respectively (Fig. 3). Since 
Col IV is adsorbed to the plastic plates used in this assay 
about threefold more effectively than LN (Hall et al., 198"/), 
Col IV and LN appear to be equally effective  on a weight ba- 
sis  in  promoting  PC12 cell attachment.  Although  only a 
small percentage of PC12 cells attached to FN, attachment 
was concentration dependent, with half-maximal attachment 
occurring at '~1  lxg/ml of FN (Fig. 3). 
The specificity of PC12 cell attachment to LN and Col IV 
was demonstrated using specific antibodies. Attachment to 
LN was largely inhibited by antisera either to intact LN or 
to the E3 fragment of LN (Fig. 4 a), but was not affected by 
preimmune serum or by affinity-purified antibodies to mu- 
rine Col IV (Fig. 4 a). Previous studies have demonstrated 
that the interactions of  both sympathetic neurons and adrenal 
Figure 1. Process outgrowth by NGF-primed PC12 cells or dissociated neonatal rat sympathetic neurons (SCG) in the absence of NGE 
NGF-primed PC12 cells were passaged and grown 24 h in the absence of added NGF on substrates coated with 1 mg/ml poly-D-lysine 
(A), 10 ~tg/ml LN (B), or 20 I.tg/ml FN (C). Rat sympathetic neurons were cultured 16 h in the absence of added NGF on substrates coated 
with  1 mg/ml poly-o-lysine (D),  10 Ixg/ml LN (E), or 20 gg/ml FN (F). Bar, 10 ~tm. 
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IV but not on FN or poly-D-lysine.  PC12 
cells were passaged with PBS/5 mM EDTA 
and grown in serum-free medium with 1 mg/ 
ml BSA for 2 h on (A) LN (10 lxg/ml), (B) 
Col IV (5 lxg/ml), (C) FN (100 ~tg/ml), or 
(D) poly-~lysine (1 mg/ml). Arrowheads in 
A and B mark phase-dark cells that have 
spread  on  LN  and  Col  IV,  respectively. 
Cells on FN or poly-D-lysine (C and D) do 
not spread appreciably as indicated by their 
round, phase-bright appearance.  (E and F) 
The anti-ECMR serum causes detachment 
of PCI2 ceils that have spread on LN or Col 
IV. After PC12 cells were allowed to attach 
and  spread  for  5  h  in  serum-containing 
medium on  LN  (E)  or Col  IV  (iv),  the 
anti-ECMR serum was added to a final con- 
centration of 1%. Cells rounded up within 
1 h after addition of  the anti-ECMR serum. 
Normal goat serum had  no effect on cell 
morphology (not shown).  Bar,  10 Ixm. 
chromaflin cells with intact LN are inhibited by antibodies 
to the E3 fragment of LN (Edgar et al.,  1984; Acheson et 
al.,  1986).  Our results  extend these  observations  to PC12 
cells  and  suggest  a  common specificity  with  which  PC12 
cells and sympathetic neurons interact with LN. PC12 cell 
attachment to Col IV was inhibited by affinity-purified anti- 
Col IV antibodies but was largely unaffected by anti-LN or 
anti-LN fragment E3 sera (Fig.  4  a). 
PC12 cell attachment to LN, Col IV, and FN was studied 
in the presence of a  hexapeptide  (GRGDSP), derived from 
a  cell  binding  domain  of FN,  and  a  control  hexztpeptide 
(GRGESP) which lacks blocking activity (Pierschbacher and 
Ruoslahti,  1984a, b). In separate experiments, the GRGDSP 
peptide, but not GRGESP, inhibited the attachment of BHK 
fibroblastic cells and primary rat muscle-derived fibroblasts 
to FN substrates (unpublished observations). The RGD-con- 
raining hexapeptide  inhibited the small percentage of PC12 
cells that attached to FN-coated substrates,  while the RGE- 
containing hexapeptide had no detectable blocking activity 
(Fig.  4  b).  Neither peptide  had noticeable effects on PC12 
cell attachment to LN or Col IV (Fig.  4  b). 
Effects of  Antisera to Purified Mammalian ECM 
Receptor Preparations on PC12 Cell Attachment to 
ECM Proteins 
Two different antisera to mammalian cell surface proteins in- 
volved in adhesion to ECM  proteins  were tested  for their 
effects on PC12 cell attachment to LN, Col IV, and FN. The 
anti-ECMR serum was prepared against a purified prepara- 
tion of adhesion-related 140-kD BHK cell surface glycopro- 
teins and induces the detachment of a wide variety of adher- 
ent murine and rat cell types when added to their culture 
medium  at  a  concentration  of  1%  (Knudsen  et  al.,  1981; 
tO0 - 
80- 
i  60- 
~  40- 
I  i  o.01  0.1  11.0  I;.0  t;O 
Protein concentration (,ug/ml) 
Figure 3. Concentration-dependent  attachment of PCI2 cells to LN, 
Col IV, and FN. [3~S]Methionine-labeled PC12 cells were allowed 
to attach for 90 min at 37~  to substrates coated with varying con- 
centrations  of LN (open circles), Col IV (open triangles), or FN 
(solid circles). After removal of nonadherent cells,  attached  cells 
were solubilized in 1% SDS and counted. Each value represents the 
mean and standard  deviation  of determinations  made on triplicate 
cultures run in parallel and is expressed  as percent of attachment 
to the positive  control, poly-o-lysine. 
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Figure 4. Specificity of PC12 cell attachment to LN, FN, and Col 
IV. (A) PC12 cell attachment to substrates coated with LN (1 pg/ml; 
open bars) or Col IV (0.5 Ixg/ml;  solidbars) was studied in the pres- 
ence of preimmune  rabbit  serum (NRS; 1:20 dilution),  a rabbit 
anti-LN serum (1:20 dilution),  a rabbit antiserum to the E3 frag- 
ment of LN (anti-E3; 1:20 dilution), normal rabbit IgG (RIgG; 50 
Ixg/ml), or affinity-purified rabbit anti-Col IV IgG (50 Ixg/ml). At- 
tachment is expressed as percent of the positive control,  poly-o- 
lysine.  The mean  and  standard  deviation  of triplicate  points  is 
shown for each condition. (B) Effects of RGD-containing hexapep- 
tides on PC12 cell attachment. Cells were allowed to attach to LN 
(t0 txg/ml; open bars), Col IV (2 txg/ml; solid bars), or FN (20 
gtg/ml; stippled  bars) in the presence of  2 mg/ml of  the control hexa- 
peptide, GRGESP (RGES), or in the presence  of 2 mg/ml of the 
hexapeptide GRGDSP  (RGDS). Values represent  the  mean and 
standard deviation of  determinations made on triplicate cultures run 
in parallel and are expressed as percent of  the positive control, poly- 
D-lysine. Attachment to LN, Col IV, or FN in the  presence  of 
GRGESP was not significantly different from attachment in the ab- 
sence of added peptides. 
in the continued presence of 50 ng/ml NGF extended neu- 
rites rapidly and profusely (Fig. 6 A). Process outgrowth on 
LN in the presence of NGF was more pronounced than that 
seen on LN in the absence of NGF illustrated in Fig.  1 B. 
This response was completely inhibited by a  1% concentra- 
tion of the anti-ECMR serum (Fig. 6 B). When dose depen- 
dence was examined, half-maximal inhibition of  process out- 
growth occurred at a 0.2 % concentration of the anti-ECMR 
serum (not shown), and appeared to be primarily a result of 
inhibiting cell attachment,  spreading, and filopodial exten- 
sion on the LN substrate (arrowhead in Fig. 6 B). Process 
outgrowth by NGF-primed PC12 cells on poly-D-lysine sub- 
strates in the presence of 50 ng/ml NGF was modest, though 
clearly less than on LN substrates (compare Fig. 6, A and 
C).  A  2%  concentration  of the  anti-EMCR  serum  com- 
pletely inhibited NGF-stimulated process outgrowth on poly- 
o-lysine substrates (Fig. 6 D), while the same concentration 
of the control  serum had no effect (Fig.  6  C).  PC12 cell 
attachment to poly-D-lysine was  not affected by the anti- 
ECMR serum, however, as is apparent from the presence of 
microspikes in contact with the substrate (arrowheads in Fig. 
6 D). The effects of the anti-ECMR serum on process out- 
growth on either LN or poly-o-lysine substrates appeared to 
be reversible after removal of the antibody (Fig. 6 E and F). 
Sympathetic neuronal process outgrowth on LN substrates 
was also sensitive to the anti-ECMR serum. Neurons cul- 
Damsky et al., 1982). A 1% concentration of the anti-ECMR 
serum largely prevented PC12 cell attachment to LN, Col IV, 
and FN, while the same concentration of the control serum 
did not (Fig.  5 A).  F=b fragments of anti-ECMR IgG also 
inhibited attachment to LN, Col IV, and FN by >90% (Fig. 
5 A), and this inhibition was concentration dependent (not 
shown). The effects of the anti-ECMR serum were specific 
for ECM-derived substrates: attachment to poly-o-lysine or 
to the  surfaces of a  mouse muscle cell line (C2) was not 
affected by concentrations  of serum fourfold higher  than 
those needed to effectively inhibit attachment to LN, Col IV, 
or FN (Fig. 5 A). In addition to preventing the initial adhe- 
sion of PC12 cells to LN or Col IV, the anti-ECMR serum 
caused a rapid detachment of cells that had already spread 
on LN or Col IV (Fig.  2 E  and F). 
Antibodies to a  purified FN receptor heterodimer max- 
imally inhibit CHO cell attachment to FN at a concentration 
of 10 mg/ml (Brown and Juliano, 1986). This high concentra- 
tion of anti-FNR IgG specifically inhibited PC12 cell attach- 
ment to FN and LN without noticeably affecting attachment 
to either Col IV or poly-o-lysine (Fig. 5 B). Attachment to 
FN was also inhibited ",,90% by concentrations of the anti- 
FNR IgG (1 mg/ml) that had little effect on attachment to LN 
(Fig. 5 B). Anti-FNR IgG inhibition of PC12 cell attachment 
to LN and FN was also concentration dependent (not shown). 
Effects of  the Anti-ECMR Serum on Process 
Outgrowth by PCI2 Cells and Sympathetic Neurons 
To study the effects of the anti-ECMR serum on PC12 cell 
process outgrowth, NGF-primed PC12 cells were passaged 
onto LN-coated substrates in the presence of the anti-ECMR 
serum or a control serum. Cells passaged onto LN substrates 
["] Controt serum 
A  ￿9  Anti-ECMR serum 
'~'~=  ~  8~  l  ~  =. 1~176  60  20  4o  ~i~  I ~  ~=.~_ ~  ~  N A~,i-Ec~R  F,,,, 
0  LN  Col IV  FN  C2 Cells 
B 
100 1  r~  I-T.lmTL,T_  [~] P  r  ei  .....  IgG 
I  111  ! 
[]  Anti-FNR IgG 10mg/ml 
| 
":~  40 
~  2o 
o  Imiil  rS - 
PDL  LN  Col IV  FN 
Figure 5. Effects  of anti-ECMR  and anti-FNR  on PCL2  ceil attach- 
ment to adhesive  substrates.  Substrates  were coated with either 
poly-D-lysine  (PDL; ] mg/ml), LN (3 I~g/ml), Col IV (2 I~g/ml), 
FN(20 p.g/l~l),  or C2 cells (l,000 cells/ram2).  (,4) PCI2 cells were 
allowed to attach to various substrates in the presence of normal 
goat serum (1% concentration; 4% concentration on poly-D-lysine 
and on C2 cells; open bars), the anti-ECMR serum (1% concentra- 
tion;  4%  concentration  on poly-D-lysine and  on C2 cells;  solid 
bars), or anti-ECMR F~ (1 mg/ml; sn'ppled bars). (B) PC12 cells 
were allowed to attach  to various  substrates  in the  presence  of 
preimmune goat IgG (open bars; 10 mg/ml on poly-v-lysine, LN, 
and Col IV; 1 mg/ml on FN), or anti-FNR IgG (solid bars: 1 mg/ 
ml; stippled bars: 10 mg/ml). Values represent the mean and stan- 
dard deviation of determinations made on triplicate cultures run in 
parallel and are expressed as percent of  the positive control, poly-D- 
lysine, in the absence of added antibodies. 
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on process outgrowth by NGF-primed PCI2 
cells or neonatal rat sympathetic neurons. 
PC12 cells  that  were primed for  10 d  in 
50 ng/ml NGF were passaged  in the con- 
tinued presence of 50 ng/ml NGF onto sub- 
strates coated with LN (10 gg/ml; A, B, and 
E) or poly-D-lysine (1 mg/ml; C, D, and F) 
and grown 24 h in the presence of normal 
goat serum (2% concentration; A and C) or 
goat anti-ECMR serum (1%  in B; 2%  in 
D).  Arrowhead  in B denotes  a  clump of 
cells that are not well attached or spread and 
have failed  to extend  neurites  on the  LN 
substrate in the presence of the anti-ECMR 
serum. Arrowheads  in D denote ceils that 
are apparently well attached to the poly-o- 
lysine  substrate  but  lack  neurites  in  the 
presence of the  anti-ECMR serum. Note 
NGF-stimulated process outgrowth is more 
pronounced  on LN than on poly-D-lysine 
(compare A and  C).  PCI2 cells recovered 
the ability to grow neurites when cultured in 
the continued presence of 50 ng/ml NGF an 
additional 24 h on LN (E) or poly-D-lysine 
(F) after removal of  the anti-ECMR serum. 
G and H: Effects of anti-ECMR serum on 
sympathetic  neuronal  process  outgrowth. 
Neonatal  rat  sympathetic  neurons  were 
grown 12 h on mixed LNlpoly-I)-lysine sub- 
strates in the presence of  control goat serum 
(0.6% concentration; G) or the anti-ECMR 
serum  (0.3%  concentration,  H).  Arrow- 
head in H marks one of  several neuronal cell 
bodies that has been prevented from grow- 
ing neurites  on LN in the presence  of the 
anti-ECMR serum.  Bar,  10 l~m. 
tured on a  mixed substrate of LN and poly-D-lysine in the 
presence of control  serum  exhibited  profuse process  out- 
growth (Fig. 6 G). This response was completely prevented 
by the anti-ECMR serum (Fig. 6 H) and when dose depen- 
dence was examined, half-maximal inhibition was achieved 
at  a  0.04%  concentration  of the  anti-ECMR  serum  (not 
shown). The anti-ECMR serum appeared not to affect neu- 
ronal  adhesion  to  the  mixed  LN/poly-~lysine  substrates 
(Fig. 6 H). However, when LN was used to coat a substrate 
to which neurons did not readily adhere, namely glass cover- 
slips, neuronal attachment to LN was inhibited ,o80% by the 
anti-ECMR serum (not shown). 
Characterization of  PCl2 Cell Proteins Recognized by 
the Anti-ECMR and Anti-FNR sera 
PC12 cell proteins recognized by anti-ECMR and anti-FNR 
antibodies were identified by immunoprecipitation of radio- 
labeled cells followed by SDS-PAGE analysis (Fig. 7). When 
octylglucoside extracts of surface-labeled PCI2 ceils were 
immunoprecipitated with the anti-ECMR serum, three prom- 
inently  labeled protein bands were identified.  Under non- 
reducing conditions these proteins migrated as diffuse bands 
with apparent molecular masses centered at  120, 140, and 
180 kD (Fig. 7, lane 2). Long autoradiographic exposures of 
some of these immunoprecipitates revealed the presence of 
a very faintly labeled protein band at "o60 kD ~ig. 7 A, lane 
3). A faint protein band at ,o170 kD under nonreducing con- 
ditions  was  nonspecifically  immunoprecipitated  in  equal 
amounts by the anti-ECMR serum and a control goat serum 
(Fig. 7 A, lanes I and 2). Under reducing conditions, the mo- 
bility of this nonspecific protein band appeared to shift from 
170 to ,,o40 kD (Fig. 7 A, compare lanes I  and 4). When the 
proteins bound by the anti-ECMR  serum were separated 
under reducing conditions, the  120- and  140-kD bands ap- 
peared to merge into a diffuse band centered at "o130 kD and 
the faint 60-kD protein shifted to "o75 kD (Fig. 7 A, lane 5). 
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tion and 7% SDS-PAGE anal- 
ysis  of surface-iodinated (A 
and D),  [3H]glucosamine-la- 
beled (B), or 32P-labeled (C) 
proteins with the anti-ECMR 
serum (A-C) or the anti-FNR 
IgG (D). (A) Surface-labeled 
PC12 cells were immunopre- 
cipitated with control goat se- 
rum (lane 1, nonreduced; lane 
4, reduced), anti-ECMR  se- 
rum  (lanes 2  and  3,  nonre- 
duced; lane 5, reduced; lane 3 
is an overexposure of lane 2 
to facilitate visualization of a 
faintly  labeled  60-kD protein), 
preimmune rabbit serum (lane 
6,  reduced), anti-Ng-CAM 
(lane  7,  reduced) or anti-N- 
CAM (lane 8, reduced). (B) [3H]glucosamine-labeled  PC12 cells were immunoprecipitated  with control goat serum (lane 1, nonreduced) 
or anti-ECMR serum (lane 2, nonreduced; lane 3, reduced). (C) 32p-labeled PC12 cell proteins were immunoprecipitated  with control 
goat serum (lane 1, nonreduced) or anti-ECMR serum (lane 2, nonreduced). (D) Immunoprecipitation  of surface-labeled  BHK (lanes 1 
and 2), NRK (lanes 3 and 4), or PC12 (lanes 5-7) cells with preimmune IgG (lanes 1, 3, and 5, nonreduced) or anti-FNR IgG (lanes 
2, 4, and 6, nonreduced; lane 7, reduced). Molecular mass markers indicated  are myosin  (200 kD), ~galactosidase (116 kD), phosphorylase 
a (97 kD), and BSA (68 kD). 
Merging of the 120- and 140-kD bands upon reduction ap- 
peared to be the result of a slight increase in the mobility of 
the 140-kD protein and a concomitant decrease in the mobil- 
ity of the 120-kD protein. Identical proteins were immuno- 
precipitated by the anti-ECMR serum from extracts of  labeled 
PC12 cells prepared with 1% Triton X-100 (not shown). The 
proteins recognized by the anti-ECMR serum were distinct 
from cell--cell  adhesion molecules recognized by anti-N- 
CAM or anti-NILE (anti-Ng-CAM) antibodies (Fig. 7 A, 
lanes 6--8). 
To determine if  proteins recognized by the anti-ECMR se- 
rum are glycoproteins synthesized by PC12 cells, [3H]glu- 
cosamine-labeled cells were immunoprecipitated as above 
(Fig. 7 B).  The anti-ECMR specifically recognized three 
prominently labeled glycoprotein bands  of  120, 140, and 
180 kD and a weakly labeled glycoprotein of 60 kD under 
nonreducing conditions (Fig. 7 B, lane 2).  Under reducing 
conditions, the 120- and 140-kD bands appeared to migrate 
as a single diffuse band at ,x,130 kD and the 60 kD protein 
shifted to *75 kD (Fig. 7 B, lane 3). The iodinated 170-kD 
protein that was nonspecifically immunoprecipitated by the 
control  goat serum  (Fig.  7  A,  lane 1)  was unlabeled by 
[3H]glucosamine  (Fig. 7 B, lane 1) and, therefore, may be 
a serum protein adsorbed to PC12 cell surfaces. 
To determine if any of the PC12 cell glycoproteins recog- 
nized by the anti-ECMR serum are phosphoproteins, 32p-la- 
beled PC12 cells were immunoprecipitated with the anti- 
ECMR serum or with control goat serum. A single labeled 
protein migrating at --120 kD under nonreducing conditions 
was specifically immunoprecipitated by the anti-ECMR se- 
rum (Fig.  7  C, lane 2).  Based on its ability to label with 
[t25i] '  [32p], and [3H]glucosamine,  the 120-kD glycoprotein 
is likely to be an integral membrane glycoprotein with ex- 
posed cytoplasmic and extracellular domains. 
Proteins recognized by the anti-FNR IgG were identified 
in 1% Triton X-100 extracts of surface-labeled BHK, NRK, 
and PC12 cells using anti-FNR IgG coupled to Affi-gel 10 
(Fig. 7 D).  Immunoprecipitation of a control hamster cell 
line, BHK, with anti-FNR IgG yielded two diffuse protein 
bands of Mr 110 and 130 kD under nonreducing conditions 
0:ig. 7 D, lane 2). These two proteins are probably identical 
to proteins recognized by this antiserum on CHO cells ~rown 
and Juliano, 1986) and constitute an FN receptor heterodi- 
mer (Brown and Juliano, 1985, 1986; see also Pytela et al., 
1985). Immunoprecipitation of surface-labeled PC12 cell ex- 
tracts with the anti-FNR IgG identified three labeled PC12 
celt protein bands migrating at 120, 140, and 180 kD under 
nonreducing conditions (Fig. 7 D, lane 6).  Upon reduction 
of disulfide bonds, the 120- and 140-kD bands appeared to 
migrate as a single diffuse band centered at 130 kD (Fig. 7 
D, lane 7). The PC12 cell proteins recognized by the anti- 
FNR IgG comigrated with those recognized by the anti- 
ECMR serum under both reducing and nonreducing condi- 
tions. Immunoprecipitation of another rat cell line, NRK, 
with the anti-FNR IgG identified predominantly four la- 
beled proteins (Fig. 7 D, lane 4).  Three of these appeared 
to correspond to the 120-, 140-, and 180-kD proteins in PC12 
cells. The fourth, a diffuse band centered at ~160 kD under 
nonreducing conditions, was absent from PC12 cell extracts 
(Fig. 7 D, compare lanes 4 and 6). 
The 120-kD PCI2 Cell Glycoprotein Is Related 
to the  ~-Subunit (Band 3) of  the CSAT/lntegrin 
ECM Receptor Complex 
To determine if any of the PC12 cell proteins recognized by 
the anti-FNR or anti-ECMR sera are related to character- 
ized components of the avian CSAT/integrin ECM receptor 
complex, surface-iodinated PC12 cells were extracted in oc- 
tylglucoside and immunoprecipitated with the anti-ECMR 
serum. Bound proteins were separated on an SDS gel under 
nonreducing conditions, transferred electrophoretically to 
nitrocellulose paper, and overlaid with an antiserum to the 
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complex recognized by the CSAT mAb (Buck et al.,  1986). 
The CSAT mAb itself  could not be used in this protocol since 
it does not react with SDS-denatured proteins and does not 
cross react with rat proteins. Autoradiography of the nitro- 
cellulose revealed proteins of 120, 140, and 180 kD that were 
immunoprecipitated by the anti-ECMR  serum (Fig.  8 A, 
lanes I  and 2). Specific binding of the anti-CSAT band 3 se- 
rum to proteins immunoprecipitated by the anti-ECMR se- 
rum, monitored with a  horseradish peroxidase-conjugated 
secondary antibody, was confined to a  single protein band 
centered at 120 kD (Fig. 8 A, lanes 3 and 4). Thus, the 120- 
kD glycoprotein recognized by the anti-ECMR serum cross 
reacts with antibodies to band 3 of the avian CSAT/integrin 
ECM receptor complex. 
When the anti-CSAT band 3 serum was used to immuno- 
precipitate proteins from octylglucoside extracts of surface- 
labeled PC12 cells, the 140- and 180-kD glycoproteins were 
brought down in addition to the 120-kD glycoprotein (Fig. 
8 B, lanes 2 and 4). The mobilities of the 120- and 140-kD 
proteins under nonreducing conditions were distorted due to 
the presence of nonreduced rabbit IgG running at ,x,120-150 
kD. An additional protein at 95 kD under nonreducing con- 
ditions was also recognized by this serum (Fig. 8 B, lane 2). 
Under  reducing  conditions,  the  120  ~ and  1400kD protein 
bands appeared to merge into a single diffuse band centered 
at ~130 kD and the 180-kD protein was clearly visible (Fig. 
8 B, lane 4). These observations, coupled with the fact that 
the anti-CSAT band 3  serum recognized only the  1200kD 
glycoprotein in antigen blots (Fig. 8 A, lane 3), suggest that 
the 140- and  180-kD proteins are noncovalently associated 
with the 120-kD protein in detergent extracts of PC12 cells. 
Discussion 
Studies aimed at the molecular characterization of neuronal 
interactions with ECM proteins are made difficult by the 
need for pure neuronal preparations in quantities suitable for 
cell biological and biochemical analysis. Some of these diffi- 
culties can be circumvented by studying cell lines with neu- 
ronal characteristics. Observations presented here show that 
the interactions of  the PC12 cell line with LN and other ECM 
proteins approximate those of neurons. Firstly, rapid, NGF- 
independent process outgrowth by NGF-primed PC12 cells 
in response to LN and FN substrates is similar to the re- 
sponse of sympathetic neurons on these substrates (cf. Table 
I and Fig. 1). Secondly, PC12 cells and sympathetic neurons 
both interact selectively with distinct structural domains of 
LN and FN, suggesting that they share receptors with com- 
mon specificities. In the case of LN, both cell types interact 
with a domain at or near the end of the long arm of the cruci- 
form LN molecule (cf. Fig. 4 A; see also Edgar et al., 1983; 
Acheson et al.,  1986;  Engvall et al.,  1986).  Cell  surface 
receptors for LN on PC12 cells and sympathetic neurons may 
be structurally homologous, since the anti-ECMR serum in- 
hibits attachment and process outgrowth of both cell types 
on LN substrates (cf. Fig. 6). In the case of FN, PC12 cells 
and sympathetic neurons appear to interact with a domain 
that contains the sequence RGDS (Fig. 4 B; see also Rogers 
et al.,  1985).  Finally, PCI2 cell attachment to the surfaces 
of a  mouse muscle cell line,  C2,  is  not inhibited by the 
anti-ECMR serum (cf. Fig. 5). Although C2 cells make LN 
Figure 8.  (A) Relationship of the  120-kD PCI2 cell surface gly- 
coprotein  recognized by the  anti-ECMR serum  to the  integrin 
[3~-subunit (band 3) of the CSAT/ECM receptor complex. Surface- 
iodinated PC12 cell proteins were immunoprecipitated with the 
anti-ECMR  serum, separated on a 7 % polyacrylamide gel under 
nonreducing  conditions,  and  transferred  electrophoreticaUy to 
nitrocellulose paper. The nitrocellulose was cut into tv~ unequal 
strips and overlaid with either the anti-CSAT band 3-specific se- 
rum or a control rabbit serum. Lanes I and 2: Autoradiograms of 
nitrocellulose strips showing iodinated PC12 cell proteins immuno- 
precipitated by the anti-ECMR serum. Lane 3: Horseradish peroxi- 
dase-reaction  product  identifying anti-CSAT band 3 antibodies 
bound to nitrocellulose strip shown in lane 1. Lane 4: Horseradish 
peroxidase-reaction product identifying control rabbit serum anti- 
bodies bound to the nitrocellulose strip shown in lane 2. Note that 
the anti-CSAT band 3 antibodies specifically recognize only the la- 
beled 120-kD protein bound by the anti-ECMR  serum. A second 
ualabeled protein band is recognized by both the anti-CSAT band 
3 and normal rabbit serum (lanes 3 and 4). (B) Immunoprecipita- 
tion of detergent extracts of surface-iodinated PC12 cells with the 
anti-CSAT band 3 serum. Lanes I and 3: Proteins immunoprecipi- 
tated by control rabbit serum analyzed under nonreducing (lane 1) 
or reducing (lane 3) conditions. Lanes 2 and 4:PC12 cell proteins 
immunoprecipitated with anti-CSAT band 3 serum analyzed under 
nonreducing (lane 2) or reducing (lane 4) conditions. In lane 2, the 
juxtaposition of the 120- and 140-kD  proteins is distorted due to the 
presence  of nonreduced  anti-CSAT  band  3  IgG  migrating at 
•120-150  kD. Molecular mass markers indicated are myosin (200 
kD), [$-galactosidase (116 kD), phosphorylase a (97 kD), and BSA 
(68 kD). 
and can express it on their surfaces (Olwin and Hall, 1985), 
other proteins, most notably cell-cell adhesion molecules, 
are likely to contribute to PC12 cell attachment to C2 cell 
surfaces. In these types of interactions, PC12 cells may also 
behave like neurons, whose interactions with a  variety of 
nonneuronal cells (e.g., Schwann cells, myotubes, and astro- 
cytes) are mediated by a combination of  both ECM receptors 
and call-cell adhesion molecules (Tomaselli et al.,  1986a; 
Bixby et al.,  1987). 
The ability of F~b fragments of anti-ECMR IgG to inhibit 
attachment of  PC12 cells to LN, FN, and Col IV suggests that 
PC12 cell surface proteins recognized by this antiserum are 
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Col IV,  and FN.  Two  lines of evidence suggest that the 
anti-ECMR serum acts directly to inhibit receptors for ECM 
proteins: (a) We have used the anti-ECMR serum to purify 
the 120-, 140-, and 180-kD glycoproteins from PC12 cells. 
When  preincubated  with  the  anti-ECMR  serum,  these 
purified proteins completely neutralize the adhesion-block- 
ing activity of this serum, demonstrating that all of the ad- 
hesion-blocking activity can be accounted for by proteins 
that  are  immunoprecipitated by  the  anti-ECMR  serum. 
(Tomaselli, K., C. H. Damsky, and L. E  Reichardt, manu- 
script in preparation). (b) The proteins immunoprecipitated 
from PC12 cells by the anti-ECMR serum bear a  strong 
resemblance to receptors for ECM proteins purified from 
other sources, in particular to glycoproteins of ~110, 140, and 
160  kD  immunoprecipitated from avian myoblasts, fibro- 
blasts, and retinal neurons by the CSAT and JG22 antibodies 
(Chapman, 1984; Knudsen et al., 1985; Horwitz et al., 1985, 
1986;  Hasegawa et al.,  1985; Akiyama et al.,  1986; Bo- 
zyczko and Horwitz,  1986; Hall et al.,  1987). The ECM 
receptor proteins recognized by the CSAT and JG22 antibod- 
ies on avian cells belong to the integrin family of adhesive 
protein receptors. Members of this receptor family are char- 
acterized by a  heterodimeric structure in which different 
tz-subunits are noncovalently  complexed to a common 13-sub- 
unit (Pytela et al.,  1986; Kishimoto et al.,  1987; Hemler et 
al., 1987; reviewed in Hynes, 1987). Sequence homology of 
cDNA clones encoding the CSAT band 3 glycoprotein with 
cDNAs encoding a human FN receptor 13-subunit and the 
13-subunit of  the leukocyte  adhesion receptors has established 
that the ll0-kD CSAT band 3 glycoprotein is a 13~-subunit of 
the integrin family (Tamkun et al.,  1986; Kishimoto et al., 
1987; Hynes, 1987). A functional association between band 
3 and one or more putative Q-subunits (either the 140- [band 
2] or 160-kD [band 1] proteins) is required for LN and FN 
binding (Buck et al.,  1986). The CSAT mAb, which binds 
to band 3 in equilibrium gel filtration experiments (Buck et 
al.,  1986), inhibits cell attachment to LN, FN, and Col IV 
(Horwitz et al.,  1985; Hall et al.,  1987). 
By analogy to the ECM receptor proteins recognized by 
the CSAT antibody on avian cells, the PC12 cell glycopro- 
teins described here and identified by the anti-ECMR and 
anti-FNR sera appear to belong to the integrin family of 
adhesive protein  receptors.  The  120-kD  glycoprotein ap- 
pears to be a I~-like subunit since it is recognized by anti- 
bodies to avian integrin I~ (anti-CSAT band 3;  cf. Fig. 8 
A). Also, like CSAT-band 3, the 120-kD PC12 cell protein is 
a phosphoprotein (el. Fig. 7 C; Hirst et al., 1986). The 140- 
and 180-kD glycoproteins may correspond to r  that 
are noncovalently associated with the  120-kD  131-subunit, 
since antibodies that recognize only the 120-kD glycoprotein 
band (anti-CSAT band 3) coprecipitate the 140- and 180-kD 
proteins  (cf Fig.  8  B).  In  a  similar  fashion,  antibodies 
directed against the common 130-kD 131-subunit of the hu- 
man  T  cell VLA protein  heterodimers  coprecipitate  five 
different ~t-subunits in the 150-200-kD range (Hemler et al., 
1987). Some of  the very late activation (VLA) protein hetero- 
dimers have recently been shown to cross react with poly- 
clonal antibodies to the avian CSAT/integrin complex and to 
be involved in cell attachment to LN and FN (Takada et al., 
1987). Although initially discovered and characterized on 
human T cells (Hemler et al., 1985, 1987), the VLA protein 
heterodimers are also present on human neuronal cell lines 
(Pischel et al.,  1986) where they may subserve neuronal 
adhesion to ECM proteins. Although the observations pre- 
sented above suggest that the PC12 cell proteins described 
here function as receptor heterodimers for ECM proteins, 
definitive statements concerning structure and ligand binding 
await experiments with the purified receptor proteins. 
PC12 cells attach and spread poorly on FN in comparison 
with LN and Col IV. One possible explanation for this obser- 
vation is that PC12 cells express a low level of FN receptors 
on their surface relative to other cell types that adhere well 
to FN (e.g., fibroblasts). This is suggested by the fact that 
anti-FNR IgG inhibits PC12 cell attachment to FN at con- 
centaations (1 mg/ml) that have little effect on CHO cell at- 
tachment to FN (see Brown and Juliano, 1986). Since mam- 
malian FN receptors are a/13 heterodimers (Pytela et al., 
1985; Patel and Lodish, 1986; Brown and Juliano, 1986), ab- 
sence or low level expression of either the tl- or 13-subunit 
could account for the low level of PC12 cell attachment to 
FN. The rat fibroblastic cell line, NRK, attaches well to FN, 
in addition to LN and Col IV (Tomaselli, K., unpublished 
observations). Immunoprecipitation of surface-labeled NRK 
cells with the anti-FNR IgG identifies a set of proteins simi- 
lar to those recognized in PC12 cell extracts except for an ad- 
ditional prominent band centered at 160 kD that is absent 
from PC12 extracts (cf Fig. 7 D). The correlation between 
the absence or low levels of  this surface protein on PC12 cells 
and the relative inability of these cells to attach to FN merits 
further investigation. Alternatively, PC12 cells could express 
a normal level of FN receptor heterodimers that are unable 
to bind FN, as appears to be the case for the IIb/III~ FN- 
binding heterodimer on unactivated platelets (Gardner and 
Hynes, 1985). Although a previous study (Akeson and War- 
ren, 1986) demonstrated apparently high levels of  attachment 
of PC12 cells to FN, differences in the cell line or the condi- 
tions used to measure attachment could account for the quan- 
titative differences in levels of attachment to FN seen in the 
present study. 
A distinguishing feature of several recently purified recep- 
tors for adhesive proteins is that they recognize the tripeptide 
sequence, Arg-Gly-Asp (RGD), present in the cell-binding 
domains of their cognate ligand(s) (reviewed in Ruoslahti 
and Pierschbacher,  1986). Consistent with these observa- 
tions, the low level of PC12 cell attachment to FN is inhibited 
by an RGD-containing hexpeptide (cf.  Fig. 4  B;  see also 
Akeson and Warren, 1986). This peptide has no effect, how- 
ever, on PC12 cell attachment to LN or Col IV, suggesting 
that receptors for these matrix proteins are functionally dis- 
tinct from FN receptors. Avian neural retinal cells also ap- 
pear to have distinct receptors for these matrix proteins (Hall 
et al.,  1987; see also Pytela et al.,  1985). Although Col IV 
apparently contains several RGD sequences, the same RGD- 
containing peptides that block cell attachment to FN do not 
inhibit attachment to Col IV (Pierschbacher et al., 1984a, b; 
see also Dedhar et al., 1987). It is presently unknown whether 
LN contains an  RGD  sequence,  however,  a  nonapeptide 
(CDPGYIGSR) derived from a LN B1 chain sequence has 
recently been shown to inhibit the attachment of epithelial 
cells to intact LN (Graf et al.,  1987). This peptide appears 
to compete for the binding of a  high affinity 68-kD  LN- 
binding protein to LN (Graf et al., 1987). The nonapeptide 
sequence, and presumably the 68-kD LN receptor-binding 
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LN molecule.  This site is distinct from the PC12 cell and 
neuronal-binding site located near the end of the long arm 
of LN (Edgar et al.,  1984; Engvall et al.,  1986).  PCI2 cell 
interactions  with LN  appear  not to involve a  68-kD  LN- 
binding protein similar to that described on other cell types 
(Malinoff and Wicha,  1983; Lesot et al.,  1983; Terranova et 
al.,  1983),  since  antibodies  to  an  endothelial  cell  68-kD 
LN-binding protein failed to detect a 68-kD protein in PC12 
cell extracts by immunoprecipitation or antigen blotting (un- 
published observations). 
PC12 cell and neuronal surface proteins recognized by the 
anti-ECMR serum appear to be involved in two related but 
separable phenomena: attachment and process outgrowth on 
LN-coated  substrates.  We have  previously  shown that ho- 
mologous receptors defined by the CSAT antibody on avian 
neurons are required  for LN-dependent process outgrowth 
on mixed LN/poly-o-lysine substrates where neuronal  adhe- 
sion is unaffected by the CSAT antibody  (Tomaselli et al., 
1986a).  Process  outgrowth  thus  appears  to  require  more 
selective interations  than does adhesion. Somewhat surpris- 
ingly, results  here show that the anti-ECMR serum inhibits 
NGF-stimulated process outgrowth from NGF-primed PC12 
cells even on poly-D-lysine when attachment  is unaffected by 
the anti-ECMR serum (cf. Fig. 6). There are two possible 
explanations for this result. First, since PC12 cells do secrete 
some laminin (Lander et al.,  1985a), process outgrowth on 
poly-D-lysine could conceivably require ECM receptor inter- 
actions with PCI2 cell-derived LN. In light of this possibil- 
ity, it is interesting that antibodies to an LN-containing pro- 
tein complex inhibits NGF-dependent sympathetic neuronal 
process outgrowth on poly-D-lysine substrates (Coughlin and 
Kessler,  1982).  Alternatively,  a direct interaction of ECM 
receptors with poly-o-lysine may be required for PC12 pro- 
cess outgrowth on this substrate.  ECM proteins are clearly 
not the only ligands that can activate  the functions of ECM 
receptors,  since substrate-bound  CSAT antibody  can itself 
promote attachment and process outgrowth by avian neurons 
(Hall et al.,  1987). 
In summary, we have shown that PC12 cells are a useful 
model for studying neuronal interactions with ECM constit- 
uents.  Antibodies  that perturb  PC12 cell interactions  with 
LN, Col IV, and FN recognize predominantly three glyco- 
protein bands  of 120, 140, and 180 kD.  Based on structural 
and functional  similarities to avian  ECM  receptors recog- 
nized by the CSAT antibody,  we propose that glycoproteins 
recognized by the anti-ECMR and anti-FNR sera are mem- 
bers of the integrin  family of adhesive protein receptors and 
may be responsible, in part, for PC12 cell and neuronal inter- 
actions with LN, Col IV, and FN. 
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